Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T88569 | Target Info | |||
Target Name | Mutated oxalosuccinate decarboxylase (mIDH1) | ||||
Synonyms | PICD (mutated); Oxalosuccinate decarboxylase (mutated); NADP(+)-specific ICDH (mutated); Isocitrate dehydrogenase [NADP] cytoplasmic (mutated); IDP (mutated); IDH (mutated); Cytosolic NADP-isocitrate dehydrogenase (mutated) | ||||
Target Type | Clinical trial Target | ||||
Gene Name | IDH1 | ||||
Biochemical Class | Short-chain dehydrogenases reductase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | NADP+ | Ligand Info | |||
Canonical SMILES | C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O)C(=O)N | ||||
InChI | 1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1 | ||||
InChIKey | XJLXINKUBYWONI-NNYOXOHSSA-O | ||||
PubChem Compound ID | 5886 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 4XS3 Crystal structure of a metabolic reductase with (E)-1-benzyl-5-((1-methyl-5-oxo-2-thioxoimidazolidin-4-ylidene)methyl)pyridin-2(1H)-one | ||||||
Method | X-ray diffraction | Resolution | 3.29 Å | Mutation | Yes | [1] |
PDB Sequence |
KKISGGSVVE
12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRKPI128 IIGHHYRATD143 FVVPGPGKVE153 ITYTPSDGTQ163 KVTYLVHNFE 173 EGGGVAMGMY183 NQDKSIEDFA193 HSSFQMALSK203 GWPLYLSTKN213 TILKKYDGRF 223 KDIFQEIYDK233 QYKSQFEAQK243 IWYEHRLIDD253 MVAQAMKSEG263 GFIWACKSLG 289 MMTSVLVCPD299 GKTVEAEAAH309 GTVTRHYRMY319 QKGQETSTNP329 IASIFAWTRG 339 LAHRAKLDNN349 KELAFFANAL359 EEVSIETIEA369 GFMTKDLAAC379 IKGLPNVQRS 389 DYLNTFEFMD399 KLGENLKIKL409 AQA
|
|||||
|
||||||
PDB ID: 5DE1 Crystal structure of human IDH1 in complex with GSK321A | ||||||
Method | X-ray diffraction | Resolution | 2.25 Å | Mutation | Yes | [2] |
PDB Sequence |
KKISGGSVVE
12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGH132 HRATDFVVPG148 PGKVEITYTP158 SDGTQKVTYL 168 VHNFEEGGGV178 AMGMYNQDKS188 IEDFAHSSFQ198 MALSKGWPLY208 LSTKNTILKK 218 YDGRFKDIFQ228 EIYDKQYKSQ238 FEAQKIWYEH248 RLIDDMVAQA258 MKSEGGFIWA 268 CKNDSVAQGY285 GSLGMMTSVL295 VCPDGKTVEA305 EAAHGTVTRH315 YRMYQKGQET 325 STNPIASIFA335 WTRGLAHRAK345 LDNNKELAFF355 ANALEEVSIE365 TIEAGFMTKD 375 LAACIKGLPN385 VQRSDYLNTF395 EFMDKLGENL405 KIKLAQAKL
|
|||||
|
GLU17
4.670
LYS72
3.596
ALA74
4.030
THR75
3.340
ILE76
3.727
THR77
2.930
ARG82
3.108
ASN96
2.927
SER287
4.235
LEU288
4.883
GLY289
3.916
GLU306
3.528
ALA307
4.099
|
|||||
PDB ID: 3MAP Crystal structure of homodimeric R132H mutant of human cytosolic NADP(+)-dependent isocitrate dehydrogenase in complex with NADP and isocitrate | ||||||
Method | X-ray diffraction | Resolution | 2.80 Å | Mutation | Yes | [3] |
PDB Sequence |
KKISGGSVVE
12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGH132 HARATDFVVP147 GPGKVEITYT157 PSDGTQKVTY 167 LVHNFEEGGG177 VAMGMYNQDK187 SIEDFAHSSF197 QMALSKGWPL207 YLSTKNTILK 217 KYDGRFKDIF227 QEIYDKQYKS237 QFEAQKIWYE247 HRLIDDMVAQ257 AMKSEGGFIW 267 ACKNVAQGYG286 SLGMMTSVLV296 CPDGKTVEAE306 AAHGTVTRHY316 RMYQKGQETS 326 TNPIASIFAW336 TRGLAHRAKL346 DNNKELAFFA356 NALEEVSIET366 IEAGFMTKDL 376 AACIKGLPNV386 QRSDYLNTFE396 FMDKLGENLK406 IKLAQAK
|
|||||
|
GLU17
4.070
LYS72
3.696
CYS73
4.628
ALA74
3.605
THR75
2.862
ILE76
3.477
THR77
2.930
ARG82
3.142
ASN96
2.986
LEU288
3.364
GLY289
3.432
GLU306
3.429
ALA307
4.069
|
|||||
PDB ID: 3MAS Crystal structure of heterodimeric R132H mutant of human cytosolic NADP(+)-dependent isocitrate dehydrogenase in complex with NADP and isocitrate | ||||||
Method | X-ray diffraction | Resolution | 3.20 Å | Mutation | Yes | [3] |
PDB Sequence |
> Chain A
KKISGGSVVE 12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGH132 HARATDFVVP147 GPGKVEITYT157 PSDGTQKVTY 167 LVHNFEEGGG177 VAMGMYNQDK187 SIEDFAHSSF197 QMALSKGWPL207 YLSTKNTILK 217 KYDGRFKDIF227 QEIYDKQYKS237 QFEAQKIWYE247 HRLIDDMVAQ257 AMKSEGGFIW 267 ACKNGSLGMM291 TSVLVCPDGK301 TVEAEAAHGT311 VTRHYRMYQK321 GQETSTNPIA 331 SIFAWTRGLA341 HRAKLDNNKE351 LAFFANALEE361 VSIETIEAGF371 MTKDLAACIK 381 GLPNVQRSDY391 LNTFEFMDKL401 GENLKIKLAQ411 AKL> Chain B KKISGGSVVE 12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGR132 HARATDFVVP147 GPGKVEITYT157 PSDGTQKVTY 167 LVHNFEEGGG177 VAMGMYNQDK187 SIEDFAHSSF197 QMALSKGWPL207 YLSTKNTILK 217 KYDGRFKDIF227 QEIYDKQYKS237 QFEAQKIWYE247 HRLIDDMVAQ257 AMKSEGGFIW 267 ACKNYGSLGM290 MTSVLVCPDG300 KTVEAEAAHG310 TVTRHYRMYQ320 KGQETSTNPI 330 ASIFAWTRGL340 AHRAKLDNNK350 ELAFFANALE360 EVSIETIEAG370 FMTKDLAACI 380 KGLPNVQRSD390 YLNTFEFMDK400 LGENLKIKLA410 QAK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NAP or .NAP2 or .NAP3 or :3NAP;style chemicals stick;color identity;select .A:17 or .A:72 or .A:74 or .A:75 or .A:76 or .A:77 or .A:82 or .A:95 or .A:96 or .A:288 or .A:289 or .A:306 or .A:308 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:315 or .A:326 or .A:327 or .A:328 or .A:375 or .A:260 or .B:17 or .B:72 or .B:74 or .B:75 or .B:76 or .B:77 or .B:82 or .B:96 or .B:288 or .B:289 or .B:306 or .B:307 or .B:309 or .B:310 or .B:311 or .B:312 or .B:313 or .B:314 or .B:315 or .B:326 or .B:327 or .B:328 or .B:329 or .B:375; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLU17[A]
4.474
LYS72[A]
3.253
ALA74[A]
3.705
THR75[A]
2.030
ILE76[A]
3.842
THR77[A]
3.125
ARG82[A]
2.812
PRO95[A]
4.960
ASN96[A]
3.303
LEU288[A]
3.973
GLY289[A]
4.061
GLU306[A]
4.362
ALA308[A]
4.873
HIS309[A]
3.747
GLY310[A]
3.176
THR311[A]
3.117
VAL312[A]
2.494
THR313[A]
2.940
ARG314[A]
2.646
HIS315[A]
2.772
SER326[A]
4.106
THR327[A]
3.695
ASN328[A]
3.119
ASP375[A]
4.179
LYS260[A]
4.478
GLU17[B]
4.786
LYS72[B]
3.512
ALA74[B]
3.883
THR75[B]
3.058
ILE76[B]
3.757
THR77[B]
2.819
ARG82[B]
3.009
ASN96[B]
2.594
LEU288[B]
3.757
GLY289[B]
3.667
GLU306[B]
3.936
ALA307[B]
4.229
HIS309[B]
3.348
GLY310[B]
3.034
THR311[B]
3.017
VAL312[B]
2.680
THR313[B]
2.943
ARG314[B]
2.543
HIS315[B]
2.519
SER326[B]
4.425
THR327[B]
3.600
ASN328[B]
2.721
PRO329[B]
4.904
ASP375[B]
4.055
|
|||||
PDB ID: 3MAR Crystal structure of homodimeric R132H mutant of human cytosolic NADP(+)-dependent isocitrate dehydrogenase in complex with NADP | ||||||
Method | X-ray diffraction | Resolution | 3.41 Å | Mutation | Yes | [3] |
PDB Sequence |
SKKISGGSVV
11 EMQGDEMTRI21 IWELIKEKLI31 FPYVELDLHS41 YDLGIENRDA51 TNDQVTKDAA 61 EAIKKHNVGV71 KCATITPDEK81 RVEEFKLKQM91 WKSPNGTIRN101 ILGGTVFREA 111 IICKNIPRLV121 SGWVKPIIIG131 HHAATDFVVP147 GPGKVEITYT157 PSDGTQKVTY 167 LVHNFEEGGG177 VAMGMYNQDK187 SIEDFAHSSF197 QMALSKGWPL207 YLSTKNTILK 217 KYDGRFKDIF227 QEIYDKQYKS237 QFEAQKIWYE247 HRLIDDMVAQ257 ASEGGFIWAC 269 KNGYGSLGMM291 TSVLVCPDGK301 TVEAEAAHGT311 VTRHYRMYQK321 GQETSTNPIA 331 SIFAWTRGLA341 HRAKLDNNKE351 LAFFANALEE361 VSIETIEAGF371 MTKDLAACIK 381 GLPNVQRSDY391 LNTFEFMDKL401 GENLKIKLAQ411 AKL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NAP or .NAP2 or .NAP3 or :3NAP;style chemicals stick;color identity;select .A:17 or .A:72 or .A:74 or .A:75 or .A:76 or .A:77 or .A:82 or .A:96 or .A:288 or .A:289 or .A:306 or .A:307 or .A:308 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:315 or .A:326 or .A:327 or .A:328 or .A:329 or .A:375; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLU17
4.924
LYS72
3.278
ALA74
4.140
THR75
3.064
ILE76
3.690
THR77
3.218
ARG82
3.107
ASN96
3.816
LEU288
3.791
GLY289
3.869
GLU306
3.618
ALA307
4.527
ALA308
4.489
|
|||||
PDB ID: 4UMX IDH1 R132H in complex with cpd 1 | ||||||
Method | X-ray diffraction | Resolution | 1.88 Å | Mutation | Yes | [4] |
PDB Sequence |
KKISGGSVVE
12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGH132 HAYGDQYRAT142 DFVVPGPGKV152 EITYTPSDGT 162 QKVTYLVHNF172 EEGGGVAMGM182 YNQDKSIEDF192 AHSSFQMALS202 KGWPLYLSTK 212 NTILKKYDGR222 FKDIFQEIYD232 KQYKSQFEAQ242 KIWYEHRLID252 DMVAQAMKSE 262 GGFIWACKNY272 DGDVQSDSVA282 QGYGSLGMMT292 SVLVCPDGKT302 VEAEAAHGTV 312 TRHYRMYQKG322 QETSTNPIAS332 IFAWTRGLAH342 RAKLDNNKEL352 AFFANALEEV 362 SIETIEAGFM372 TKDLAACIKG382 LPNVQRSDYL392 NTFEFMDKLG402 ENLKIKLAQA 412 KL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NAP or .NAP2 or .NAP3 or :3NAP;style chemicals stick;color identity;select .A:17 or .A:72 or .A:73 or .A:74 or .A:75 or .A:76 or .A:77 or .A:82 or .A:96 or .A:277 or .A:287 or .A:288 or .A:289 or .A:306 or .A:307 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:315 or .A:326 or .A:327 or .A:328 or .A:375; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLU17
4.609
LYS72
3.421
CYS73
4.831
ALA74
3.502
THR75
2.904
ILE76
3.616
THR77
3.009
ARG82
3.005
ASN96
3.124
GLN277
3.397
SER287
4.642
LEU288
3.745
GLY289
3.668
|
|||||
PDB ID: 4UMY IDH1 R132H in complex with cpd 1 | ||||||
Method | X-ray diffraction | Resolution | 2.07 Å | Mutation | Yes | [4] |
PDB Sequence |
KKISGGSVVE
12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGH132 HRATDFVVPG148 PGKVEITYTP158 SDGTQKVTYL 168 VHNFEEGGGV178 AMGMYNQDKS188 IEDFAHSSFQ198 MALSKGWPLY208 LSTKNTILKK 218 YDGRFKDIFQ228 EIYDKQYKSQ238 FEAQKIWYEH248 RLIDDMVAQA258 MKSEGGFIWA 268 CKNGSLGMMT292 SVLVCPDGKT302 VEAEAAHGTV312 TRHYRMYQKG322 QETSTNPIAS 332 IFAWTRGLAH342 RAKLDNNKEL352 AFFANALEEV362 SIETIEAGFM372 TKDLAACIKG 382 LPNVQRSDYL392 NTFEFMDKLG402 ENLKIKLAQA412 K
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NAP or .NAP2 or .NAP3 or :3NAP;style chemicals stick;color identity;select .A:17 or .A:72 or .A:73 or .A:74 or .A:75 or .A:76 or .A:77 or .A:82 or .A:96 or .A:288 or .A:289 or .A:306 or .A:307 or .A:308 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:315 or .A:326 or .A:327 or .A:328 or .A:375; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLU17
4.607
LYS72
3.520
CYS73
4.848
ALA74
3.473
THR75
2.964
ILE76
3.628
THR77
2.964
ARG82
2.983
ASN96
3.328
LEU288
3.646
GLY289
3.715
GLU306
3.320
ALA307
4.134
|
|||||
PDB ID: 6U4J Crystal structure of IDH1 R132H mutant in complex with FT-2102 | ||||||
Method | X-ray diffraction | Resolution | 2.11 Å | Mutation | Yes | [5] |
PDB Sequence |
KKISGGSVVE
12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGH132 HAYGDQYRAT142 DFVVPGPGKV152 EITYTPSDGT 162 QKVTYLVHNF172 EEGGGVAMGM182 YNQDKSIEDF192 AHSSFQMALS202 KGWPLYLSTK 212 NTILKKYDGR222 FKDIFQEIYD232 KQYKSQFEAQ242 KIWYEHRLID252 DMVAQAMKSE 262 GGFIWACKNY272 DGDVQSDSVA282 QGYGSLGMMT292 SVLVCPDGKT302 VEAEAAHGTV 312 TRHYRMYQKG322 QETSTNPIAS332 IFAWTRGLAH342 RAKLDNNKEL352 AFFANALEEV 362 SIETIEAGFM372 TKDLAACIKG382 LPNVQRSDYL392 NTFEFMDKLG402 ENLKIKLAQA 412 KLSLE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NAP or .NAP2 or .NAP3 or :3NAP;style chemicals stick;color identity;select .A:17 or .A:72 or .A:73 or .A:74 or .A:75 or .A:76 or .A:77 or .A:82 or .A:96 or .A:277 or .A:287 or .A:288 or .A:289 or .A:306 or .A:307 or .A:308 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:315 or .A:326 or .A:327 or .A:328 or .A:375; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLU17
4.831
LYS72
3.505
CYS73
4.893
ALA74
3.651
THR75
3.193
ILE76
3.501
THR77
2.959
ARG82
3.223
ASN96
2.894
GLN277
4.511
SER287
4.166
LEU288
4.107
GLY289
3.740
GLU306
3.309
|
|||||
PDB ID: 4KZO Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate | ||||||
Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | Yes | [6] |
PDB Sequence |
KKISGGSVVE
12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGH132 HAYGDQYRAT142 DFVVPGPGKV152 EITYTPSDGT 162 QKVTYLVHNF172 EEGGGVAMGM182 YNQDKSIEDF192 AHSSFQMALS202 KGWPLYLSTK 212 NTILKKYDGR222 FKDIFQEIYD232 KQYKSQFEAQ242 KIWYEHRLID252 DMVAQAMKSE 262 GGFIWACKNY272 DGDVQSDSVA282 QGYGSLGMMT292 SVLVCPDGKT302 VEAEAAHGTV 312 TRHYRMYQKG322 QETSTNPIAS332 IFAWTRGLAH342 RAKLDNNKEL352 AFFANALEEV 362 SIETIEAGFM372 TKDLAACIKG382 LPNVQRSDYL392 NTFEFMDKLG402 ENLKIKLAQA 412 KLSL
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NAP or .NAP2 or .NAP3 or :3NAP;style chemicals stick;color identity;select .A:17 or .A:72 or .A:73 or .A:74 or .A:75 or .A:76 or .A:77 or .A:82 or .A:96 or .A:100 or .A:287 or .A:288 or .A:289 or .A:306 or .A:307 or .A:308 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:315 or .A:326 or .A:327 or .A:328 or .A:375; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLU17
4.636
LYS72
3.379
CYS73
4.719
ALA74
3.473
THR75
2.937
ILE76
3.677
THR77
3.200
ARG82
3.148
ASN96
2.811
ARG100
4.938
SER287
4.943
LEU288
3.549
GLY289
3.951
GLU306
4.686
|
|||||
PDB ID: 4L06 Crystal Structure Analysis of human IDH1 mutants in complex with NADP+ and Ca2+/alpha-Ketoglutarate | ||||||
Method | X-ray diffraction | Resolution | 2.28 Å | Mutation | Yes | [6] |
PDB Sequence |
KKISGGSVVE
12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGR132 HAYGDQDRAT142 DFVVPGPGKV152 EITYTPSDGT 162 QKVTYLVHNF172 EEGGGVAMGM182 YNQDKSIEDF192 AHSSFQMALS202 KGWPLYLSTK 212 NTILKKYDGR222 FKDIFQEIYD232 KQYKSQFEAQ242 KIWYEHRLID252 DMVAQAMKSE 262 GGFIWACKNY272 DGDVQSDSVA282 QGYGSLGMMT292 SVLVCPDGKT302 VEAEAAHGTV 312 TRHYRMYQKG322 QETSTNPIAS332 IFAWTRGLAH342 RAKLDNNKEL352 AFFANALEEV 362 SIETIEAGFM372 TKDLAACIKG382 LPNVQRSDYL392 NTFEFMDKLG402 ENLKIKLAQA 412 KLS
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NAP or .NAP2 or .NAP3 or :3NAP;style chemicals stick;color identity;select .A:17 or .A:72 or .A:73 or .A:74 or .A:75 or .A:76 or .A:77 or .A:82 or .A:96 or .A:288 or .A:289 or .A:306 or .A:307 or .A:308 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:315 or .A:326 or .A:327 or .A:328 or .A:375; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLU17
4.797
LYS72
3.416
CYS73
4.676
ALA74
3.328
THR75
2.751
ILE76
3.654
THR77
3.182
ARG82
3.343
ASN96
2.855
LEU288
3.583
GLY289
3.835
GLU306
4.074
ALA307
3.468
|
|||||
PDB ID: 6O2Z Crystal structure of IDH1 R132H mutant in complex with compound 32 | ||||||
Method | X-ray diffraction | Resolution | 2.50 Å | Mutation | Yes | [7] |
PDB Sequence |
KKISGGSVVE
12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGH132 HADQYRATDF144 VVPGPGKVEI154 TYTPSDGTQK 164 VTYLVHNFEE174 GGGVAMGMYN184 QDKSIEDFAH194 SSFQMALSKG204 WPLYLSTKNT 214 ILKKYDGRFK224 DIFQEIYDKQ234 YKSQFEAQKI244 WYEHRLIDDM254 VAQAMKSEGG 264 FIWACKNYDG274 DVQSDSVAQG284 YGSLGMMTSV294 LVCPDGKTVE304 AEAAHGTVTR 314 HYRMYQKGQE324 TSTNPIASIF334 AWTRGLAHRA344 KLDNNKELAF354 FANALEEVSI 364 ETIEAGFMTK374 DLAACIKGLP384 NVQRSDYLNT394 FEFMDKLGEN404 LKIKLAQAKL 414 S
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NAP or .NAP2 or .NAP3 or :3NAP;style chemicals stick;color identity;select .A:17 or .A:72 or .A:73 or .A:74 or .A:75 or .A:76 or .A:77 or .A:82 or .A:96 or .A:277 or .A:287 or .A:288 or .A:289 or .A:306 or .A:307 or .A:308 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:315 or .A:326 or .A:327 or .A:328 or .A:375; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLU17
4.658
LYS72
3.413
CYS73
4.822
ALA74
3.577
THR75
3.064
ILE76
3.676
THR77
2.913
ARG82
3.029
ASN96
2.940
GLN277
3.815
SER287
4.113
LEU288
4.327
GLY289
3.663
GLU306
3.700
|
|||||
PDB ID: 5LGE Crystal Structure of human IDH1 mutant (R132H) in complex with NADP+ and an Inhibitor related to BAY 1436032 | ||||||
Method | X-ray diffraction | Resolution | 2.70 Å | Mutation | Yes | [8] |
PDB Sequence |
KKISGGSVVE
12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGH132 HAYGDQYRAT142 DFVVPGPGKV152 EITYTPTYLH 170 NFEEGGGVAM180 GMYNQDKSIE190 DFAHSSFQMA200 LSKGWPLYLS210 TKNTILKKYD 220 GRFKDIFQEI230 YDKQYKSQFE240 AQKIWYEHRL250 IDDMVAQAMK260 SEGGFIWACK 270 NYDGDVQSDS280 VAQGYGSLGM290 MTSVLVCPDG300 KTVEAEAAHG310 TVTRHYRMYQ 320 KGQETSTNPI330 ASIFAWTRGL340 AHRAKLDNNK350 ELAFFANALE360 EVSIETIEAG 370 FMTKDLAACI380 KGLPNVQRSD390 YLNTFEFMDK400 LGENLKIKLA410 QAKLSL |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NAP or .NAP2 or .NAP3 or :3NAP;style chemicals stick;color identity;select .A:17 or .A:72 or .A:73 or .A:74 or .A:75 or .A:76 or .A:77 or .A:82 or .A:96 or .A:288 or .A:289 or .A:306 or .A:307 or .A:308 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:315 or .A:326 or .A:327 or .A:328 or .A:375; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLU17
4.623
LYS72
3.464
CYS73
4.850
ALA74
3.659
THR75
2.918
ILE76
3.782
THR77
3.422
ARG82
3.341
ASN96
2.973
LEU288
3.502
GLY289
3.802
GLU306
2.947
ALA307
3.561
|
|||||
PDB ID: 6O2Y Crystal structure of IDH1 R132H mutant in complex with compound 24 | ||||||
Method | X-ray diffraction | Resolution | 2.80 Å | Mutation | Yes | [7] |
PDB Sequence |
KKISGGSVVE
12 MQGDEMTRII22 WELIKEKLIF32 PYVELDLHSY42 DLGIENRDAT52 NDQVTKDAAE 62 AIKKHNVGVK72 CATITPDEKR82 VEEFKLKQMW92 KSPNGTIRNI102 LGGTVFREAI 112 ICKNIPRLVS122 GWVKPIIIGH132 HAYGDQYRAT142 DFVVPGPGKV152 EITYTPSDGT 162 QKVTYLVHNF172 EEGGGVAMGM182 YNQDKSIEDF192 AHSSFQMALS202 KGWPLYLSTK 212 NTILKKYDGR222 FKDIFQEIYD232 KQYKSQFEAQ242 KIWYEHRLID252 DMVAQAMKSE 262 GGFIWACKNY272 DGDVQSDSVA282 QGYGSLGMMT292 SVLVCPDGKT302 VEAEAAHGTV 312 TRHYRMYQKG322 QETSTNPIAS332 IFAWTRGLAH342 RAKLDNNKEL352 AFFANALEEV 362 SIETIEAGFM372 TKDLAACIKG382 LPNVQRSDYL392 NTFEFMDKLG402 ENLKIKLAQA 412 KLE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NAP or .NAP2 or .NAP3 or :3NAP;style chemicals stick;color identity;select .A:17 or .A:72 or .A:73 or .A:74 or .A:75 or .A:76 or .A:77 or .A:82 or .A:96 or .A:277 or .A:288 or .A:289 or .A:306 or .A:307 or .A:308 or .A:309 or .A:310 or .A:311 or .A:312 or .A:313 or .A:314 or .A:315 or .A:326 or .A:327 or .A:328 or .A:375; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
GLU17
4.634
LYS72
3.662
CYS73
4.643
ALA74
3.154
THR75
2.847
ILE76
3.586
THR77
3.485
ARG82
3.029
ASN96
2.841
GLN277
3.842
LEU288
3.982
GLY289
3.640
GLU306
3.553
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds. J Med Chem. 2015 Sep 10;58(17):6899-6908. | ||||
REF 2 | New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015 Nov;11(11):878-86. | ||||
REF 3 | Molecular mechanisms of "off-on switch" of activities of human IDH1 by tumor-associated mutation R132H. Cell Res. 2010 Nov;20(11):1188-200. | ||||
REF 4 | Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small molecule. J Biol Chem. 2015 Jan 9;290(2):762-74. | ||||
REF 5 | Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor. J Med Chem. 2020 Feb 27;63(4):1612-1623. | ||||
REF 6 | Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism. Biochemistry. 2013 Jul 2;52(26):4563-77. | ||||
REF 7 | Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors. J Med Chem. 2019 Jul 25;62(14):6575-6596. | ||||
REF 8 | Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo. Acta Neuropathol. 2017 Apr;133(4):629-644. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.